Skip to content
DraconiticResearch
Search Sources API
216,686 studies31 sourcesUpdated 7 min ago

Oncology

5,539 studies453 in 7 days2,591 in 30 days

Filters
Type
Date
Clear

Latest

5,539 studies

  1. Spatial compartmentalization of melanoma cell states reveals CAF-associated tumor cells with enhanced proliferative capacity
    Weilong Zheng, Huanhuan Zheng
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPhysiologyPLOS
  2. Machine learning-supported identification of necrosis in colorectal and pancreatic cancer spheroids
    Miguel Martínez Lozano, Heinz D. Wanzenboeck, Sonia Prado-López
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  3. Multi-site observational evaluation of Breast AI™-supported ultrasound risk stratification in breast cancer assessment pathways
    Kathryn Malherbe, Carol A. Benn, Gerhard Botha
    PLOS OnePeer-reviewedCC BY 4.0Full textMedical imaging & radiologyOncologyPLOS
  4. Factors affecting task shifting/sharing from physicians to pharmacists in cancer chemotherapy in Japan: A qualitative study
    Keiko Ikuta, Atsushi Yonezawa, Hiroshi Okada +6
    PLOS OnePeer-reviewedCC BY 4.0OncologyPLOS
  5. Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma
    Emeline Guiard, Florian Clatot, Caroline Even +5
    European Journal of CancerPeer-reviewedPublisher termsFull text20 citedOncologyHAL
  6. NMR spectroscopy stability studies of Ru-IM, a prodrug candidate for triple negative breast cancer
    Marayke Mayrata, Alvaro Lopez-Sanchez, Esteban Urriolabeitia +5
    Journal of Inorganic BiochemistryPeer-reviewedLicence not stated1 citedOncologyHAL
  7. Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs
    Jia Xuan Kee, Jia Ning Nicolette Yau, Ram Pravin Kumar Muthuramalingam +10
    Chemical ReviewsPeer-reviewedCC BY-NC-ND 4.0Full text25 citedOncologyHAL
  8. Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML)
    Ruoping Tang, Anne-Marie Faussat, Jean-Yves Perrot +6
    BMC CancerPeer-reviewedCC BY 4.0Full text66 citedOncologyPharmacology & toxicologyHAL
  9. PP2A Cdc55 Phosphatase Imposes Ordered Cell-Cycle Phosphorylation by Opposing Threonine Phosphorylation
    Molly Godfrey, Sandra Touati, Meghna Kataria +3
    Molecular CellPeer-reviewedCC BYFull text105 citedOncologyHAL
  10. Lorlatinib in frontline treatment of advanced ALK-positive non-small cell lung cancer: a highly efficient new standard of care but still challenging to manage
    Mylène Wespiser, Aurélie Swalduz, Maurice Pérol
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDOncologyHAL
  11. Uveal melanoma: In the era of new treatments
    Wespiser Mylène, E. Neidhardt, S. Negrier
    Cancer Treatment ReviewsPeer-reviewedLicence not stated55 citedOncologyHAL
  12. Combined prognostic value of age at onset and socioeconomic status for long-term survival in metastatic breast cancer
    Ke Zhou, Germán Cano-Sancho, Caroline Goupille +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyHAL
  13. Treatment sequences in EGFR mutant advanced NSCLC
    Wespiser Mylène, A. Swalduz, M. Pérol
    Lung CancerPeer-reviewedLicence not statedFull text16 citedOncologyHAL
  14. Colonic Metastases from Lung Adenocarcinoma Detected During an Evaluation of Recurrent Diarrhea Associated with Immune-Related Colitis
    Naohito Hashimoto, Yoshiaki Nagai, Konjo Cho +7
    Internal MedicinePeer-reviewedCC BY-NC-NDFull text1 citedOncologyJ-STAGE
  15. Neutrophil-to-lymphocyte Ratio as a Prognostic Indicator in Patients with Nursing and Healthcare-associated Pneumonia: A Retrospective Study
    Yuki Hiraoka, Takashi Ogasawara, Ei Kishimoto +6
    Internal MedicinePeer-reviewedCC BY-NC-NDFull text1 citedOncologyJ-STAGE
  16. Antigen-Guided Synthetic Receptor Engineering for Safer T Cell Immunotherapy in Solid Tumors
    Su-Jin Kang, Hyo Jung Cho, Ji-Hyeon Kim +1
    Immune NetworkPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  17. Management of diarrhea in patients receiving liposomal irinotecan-based regimens: a narrative review of mechanisms, clinical impact, and evidence-based strategies.
    Alberto Zaniboni
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  18. Pt(iv) scaffold effects on nucleolar stress and DNA damage response pathways
    Christopher R. Griffin, Victoria J. DeRose
    RSC Chemical BiologyPeer-reviewedCC BY-NC 3.0Full textOncologyPMC
  19. First-line fecal microbiota transplantation for the management of immune checkpoint inhibitor-mediated diarrhea and colitis
    Yinghong Wang, Christopher Fan, Krishnavathana Varatharajalu +29
    Cell Reports MedicinePeer-reviewedCC BY-NC-ND 4.0Full text1 citedOncologyPMC
  20. XPO1 Inhibition by Selinexor Induces Nuclear p53 and p21 Accumulation, Cell-Cycle Arrest and Apoptosis in Testicular Germ Cell Tumors
    R. Islam, A. Wladhaus, I. Bollen +8
    bioRxivPreprintCC BY-NDFull textOncologybioRxiv
  21. A Hybrid Residual-Swin Transformer Design with Attention for Prostate Cancer Segmentation
    R. Singh, S. Gupta, S. Juneja +4
    bioRxivPreprintCC BYFull textOncologybioRxiv
  22. Clustered structural variant hotspots enable oncogenic addiction and plasticity in osteosarcoma
    S. Raman, T. Kaltenbacher, D. Merrell +27
    bioRxivPreprintCC BYFull textOncologybioRxiv
  23. MetScore and classical-basal subtype intersect to define chemotherapy response and tumor microenvironment architecture in pancreatic ductal adenocarcinoma
    R. E. Preston, H. Huang, M. A. Hall +7
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  24. Cardiomyocytes upregulated PD-L1 expression to alleviate cardiac injury induced by irradiation combined with anti-PD-1 antibody: an in vitro and in vivo study
    Y. Zhou, Y. Wu, N. Zhang +5
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  25. Gap Junction Protein Connexin43 (Cx43) Promotes Glioma Invasion via the Annexin A2/MMP3 Signaling Axis
    C. Glufka, E. Ojefua, L. J. Foster +3
    bioRxivPreprintCC BYFull textOncologybioRxiv